medigraphic.com
ISSN 2007-3178 (Print)
Asociación Mexicana de Cirugía Bucal y Maxilofacial, Colegio Mexicano de Cirugía Bucal y Maxilofacial, A.C.

2018, Number 2

<< Back Next >>

Rev Mex Cir Bucal Maxilofac 2018; 14 (2)

Infiltration of plasma rich in growth factors in internal disorders of the temporomandibular joint

Picco DMI, Domínguez SP, Rosas BJV

Language: Spanish
References: 14
Page: 99-105
PDF size: 173.08 Kb.


ABSTRACT

Introduction: The internal disorders of the temporomandibular joint are caused by an abnormal relationship between the condyle, the glenoid cavity, the eminence and the articular disc. Symptoms include pain, poor mouth opening, and loss of joint function. It causes disability and polypharmacy for the patient and generates high costs in the health sector. The objective of this study was to evaluate the administration of intra-articular growth factor-rich plasma (PRFC) to reduce painful symptoms. Material and methods: Report of a series of cases where, after the administration of PRFC, pain reduction, mouth opening and joint noises were evaluated at one month and four months postoperatively. Statistical analysis was used for frequencies and percentages in the case of the qualitative variables, in the quantitative average and standard deviation, for the inference was used for non-parametric dependent groups Chi square, Friedman test with a post hoc of U Wilcoxon, all with significance level of 0.05. Results: All cases presented improvement of symptomatology, pain was the only one with statistical significance (p ‹ 0.05). Discussion: Infiltration of PRFC into ATM compared to other therapies is as effective or more efficient than other non-surgical alternatives. Conclusion: Administration of intra-articular PRFC is an efficient therapy in pain reduction.


REFERENCES

  1. Knop E, De Paula L, Fuller R. Plasma rico em plaquetas no tratamento da osteoartrite. Rev Bras Reumatol. 2015; 56 (2): 152-164.

  2. Rodríguez-Merchan EC. Intraarticular injections of platelet-rich Plasma (PRP) in the management of knee osteoartrhirits. Arch Bone Jt Surg. 2013; 1 (1): 5-8.

  3. Simental-Mendía MA, Vilchez-Cavazos JF, Martínez-Rodrígez GH. El plasma rico en plaquetas en osteoartrosis de rodilla: una alternativa de tratamiento. Artículo de revisión. Cirugía y Cirujanos. 2015; 83 (4): 352-358.

  4. Miloro M, McKnight M, Han MD, Markiewicz MR. Discectomy without replacement improves function in patients with internal derangement of the temporomandibular joint. J Craniomaxillofac Surg. 2017; 45 (9): 1425-1431.

  5. Moreno R, Gaspar CM, Jiménez TJ, Alonso HJ, Villimar A, López SP. Técnicas de obtención del plasma rico en plaquetas y su empleo en terapéutica osteoinductora. Farm Hosp. 2015; 39 (3): 130-136.

  6. Swartz M, Martínez-Sánchez G, Re L. Factores de crecimiento derivados de plaquetas y sus aplicaciones en medicina regenerativa. Potencialidades del uso del ozono como activador. Revista española de Ozonoterapia. 2011; 1 (1): 54-73.

  7. Machon V, Rehorová M, Šedý J, Foltán R. Platelet-rich plasma in temporomandibular joint osteoarthritis therapy: a 3-month follow-up pilot study. J Arthritis. 2013; 2: 112.

  8. Pihut M, Szuta M, Ferendiuk E, Zeńczak-Więckiewicz D. Evaluation of pain regression in patients with temporomandibular dysfunction treated by intra-articular platelet-rich plasma injections: a preliminary report. Hindawi Publishing Corporation. Biomed Res Int. 2014; 2014: 132369.

  9. Di Stefano D, Cazzaniga A. Técnicas de regeneración y reconstrucción en cirugía implantar. Elsevier Saunders. Milano, Italia. 2013. pp. 417.

  10. Speciali JG, Dach F. Temporomandibular dysfunction and headache disorder. Headache. 2015; 55 (S1): 72-83.

  11. Coria SL. Plasma rico en plaquetas para disminución del dolor en la porción larga de bíceps braquial, ensayo clínico cuasiexperimental realizado en pacientes del Servicio de Medicina Física y Rehabilitación, Hospital Regional 1º de Octubre, ISSSTE. Universidad Nacional Autónoma de México. México, 2015. p. 73.

  12. Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014; 5 (3): 351-361.

  13. Shanker Pal U, Mohammad S, Singh R, Das S, Singh N, Singh M. Platelet-rich growth factor in oral and maxillofacial surgery. Natl J Maxillofac Surg. 2012; 3 (2): 118-123.

  14. Raeissadat SA, Mansoor SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M et al. Knee osteoarthritis injection choices: platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskeletal Disord. 2015; 8: 1-8.




2020     |     www.medigraphic.com